Welcome To Taro U.S.A.

Taro markets a broad range of prescription and over-the-counter products in the United States.  We are a leading manufacturer and supplier of topical dermatological products and also have a growing line of solid dosage form products used mainly in cardiology and neurology.

We’re proud that millions of Americans rely on our generic pharmaceuticals and over-the-counter private-label products every year.  Whether you're a physician, pharmacist or patient, please consider this website your personal resource for learning more about Taro.


Press Releases

May 11, 2012
Taro 2011 Annual Report on Form 20-F Available
More

April 18, 2012
Kal Sundaram Appointed to Taro's Board of Directors as Chairman
More

April 05, 2012
Recent Market Activity in Taro's Common Stock
More

March 19, 2012
Taro to List on NYSE
More

February 10, 2012
Taro Provides Preliminary 2011 Full Year and Q4 Results
More

Privacy Statement   |   Terms of Use   |   Safe Harbor Statement   |   Useful Taro Links